Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin-Yao Shen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Scientific Reports|May 24, 2023
Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jawPei-An Fu, Chin-Yao Shen, Shuen-Ru Yang, et al.
Cancers|August 7, 2021
Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate CancerJui-Ming Liu, Chin-Yao Shen, Wallis C Y Lau, et al.
Age and Ageing|July 24, 2024
Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort studyYu-Chen Su, Chin-Yao Shen, Shih-Chieh Shao, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 8, 2025
Antipsychotic therapy and suicide risk in patients with treatment-resistant depression: target trial emulation framework studyDaniel Hsiang-Te Tsai, Avery Shuei-He Yang, Zi-Xuan Wong, et al.
Journal of Internal Medicine|June 7, 2023
Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort studyXinning Tong, Chin-Yao Shen, Ha-Lim Jeon, et al.
Studies in Health Technology and Informatics|August 8, 2025
Predicting Infection Risk in Rheumatoid Arthritis Patients Treated with Biological and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs: An Application of Machine LearningKuan Peng, Deliang Yang, Jiaqi Wang, et al.
BMJ Supportive & Palliative Care|February 18, 2022
Bone-targeting agents in major solid tumour metastases: a multinational cohort studyJu Hwan Kim, Chin-Yao Shen, Philip Chun-Ming Au, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 12, 2022
Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort StudyChin-Yao Shen, Philip Chun-Ming Au, Yeon-Hee Baek, et al.
Thrombosis and Haemostasis|January 30, 2026
Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An EvaluationWei Kang, Chin-Yao Shen, Michael Chun-Yuan Cheng, et al.
CNS Drugs|June 24, 2020
Application of Healthcare 'Big Data' in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)Jenni Ilomäki, J Simon Bell, Adrienne Y L Chan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|May 24, 2023
Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jawPei-An Fu, Chin-Yao Shen, Shuen-Ru Yang, et al.
Cancers|August 7, 2021
Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate CancerJui-Ming Liu, Chin-Yao Shen, Wallis C Y Lau, et al.
Age and Ageing|July 24, 2024
Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort studyYu-Chen Su, Chin-Yao Shen, Shih-Chieh Shao, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 8, 2025
Antipsychotic therapy and suicide risk in patients with treatment-resistant depression: target trial emulation framework studyDaniel Hsiang-Te Tsai, Avery Shuei-He Yang, Zi-Xuan Wong, et al.
Journal of Internal Medicine|June 7, 2023
Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort studyXinning Tong, Chin-Yao Shen, Ha-Lim Jeon, et al.
Studies in Health Technology and Informatics|August 8, 2025
Predicting Infection Risk in Rheumatoid Arthritis Patients Treated with Biological and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs: An Application of Machine LearningKuan Peng, Deliang Yang, Jiaqi Wang, et al.
BMJ Supportive & Palliative Care|February 18, 2022
Bone-targeting agents in major solid tumour metastases: a multinational cohort studyJu Hwan Kim, Chin-Yao Shen, Philip Chun-Ming Au, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 12, 2022
Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort StudyChin-Yao Shen, Philip Chun-Ming Au, Yeon-Hee Baek, et al.
Thrombosis and Haemostasis|January 30, 2026
Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An EvaluationWei Kang, Chin-Yao Shen, Michael Chun-Yuan Cheng, et al.
CNS Drugs|June 24, 2020
Application of Healthcare 'Big Data' in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)Jenni Ilomäki, J Simon Bell, Adrienne Y L Chan, et al.
Pageof 2